2023 Impact Report: A hands-on investment strategy driving positive change for the planet
Read all about how the entrepreneurs we support are working to make industry and agriculture more sustainable
Download PDFCLICK HERE TO READ THE FULL REPORT
Sofinnova Partners has been investing for more than a decade in early-stage companies that use biotechnology to make a positive environmental impact. Every year, we witness progress as we work with scientists, engineers and entrepreneurs to build successful companies.
Quantifying environmental impact is challenging, especially with early-stage companies. Instead of projecting or forecasting, we focus on setting our portfolio companies on the right track and finding the most effective ways to monitor their progress over our investment holding period.
In this annual impact report, our second, you will read about how we strive to achieve impact in four of the 17 UN Sustainable Development Goals (SDGs), and how we set Key Performance Indicators (KPIs) that are just the right mix of environmental, technical and business targets.
This year's report goes deeper into our strategy as investors and provides more fine-grained detail on a selection of our innovative portfolio companies.
You will read about how we embed impact in every stage of our investment process and see breakdowns of our portfolio in terms of the SDGs the companies are addressing, and the sectors they are targeting.
The report goes deep on a handful of the companies, including our most recent investments. You'll see what some of the CEOs say about us and explore some truly fascinating technology — all of it inspired by the natural world.
Click on the link at the top of this page for an exciting read on how our industrial biotech strategy is curing the planet, one startup at a time!
Related News
AFYREN is ramping up its efforts to create a new path for organic waste recovery
Sofinnova publishes 2023 Impact Report
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather with the appointment of CEO Michael Newton
Elicit Plant makes C&EN’s list of '10 Start-Ups to Watch'
EnginZyme produces key mRNA vaccine ingredient using biocatalysis